Pediatric midline brain tumor outcomes
Part of Cancer clinical trials.
This study looks at children under 18 with a type of brain tumor at the back of the brain (posterior fossa) to understand what affects their outcomes. It will help doctors learn more about how these tumors behave and what to expect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 18 years old.
- You have a tumor in the midline area of the back part of the brain (posterior fossa).
- You are healthy enough to have surgery to remove the tumor.
- The tumor has not spread to other parts of the body.
- All necessary medical information is available for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if intensive physical therapy helps children recover after surgery for a brain tumor at the back of the head. It is designed for kids and young adults up to age 25.
This study looks at how physical abilities and quality of life are affected in children with brain tumors. It involves physical testing and questionnaires, and aims to understand the impact of the tumor and its treatment.
This study looks at “brain biomarkers,” meaning brain signals measured on MRI and thinking/learning tests on a computer. It may help researchers understand how brain tumors affect the brain and track changes over time.
This study compares two surgical methods for treating lesions at the back of the brain (posterior fossa). It aims to see which approach leads to better recovery and fewer complications.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
This study looks at brain tumor samples from children and young adults after surgery to learn more about the tumors and find better treatments. It may help researchers develop new therapies for these tumors.
Hear when a new Pediatric Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.